Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.95 USD | +0.07% | +20.85% | -49.74% |
Financials (USD)
Sales 2024 * | 38.74M | Sales 2025 * | 50.93M | Capitalization | 63.51M |
---|---|---|---|---|---|
Net income 2024 * | -87M | Net income 2025 * | -69M | EV / Sales 2024 * | 1.64 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.25 x |
P/E ratio 2024 * |
-0.5
x | P/E ratio 2025 * |
-0.75
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.61% |
Latest transcript on Bionano Genomics, Inc.
1 day | +0.07% | ||
1 week | +20.85% | ||
Current month | +7.58% | ||
1 month | -3.70% | ||
3 months | -15.18% | ||
6 months | -39.49% | ||
Current year | -49.74% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 11-01-11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 23-09-10 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-06-30 | |
David Barker
CHM | Chairman | 82 | 10-05-10 |
Albert Luderer
BRD | Director/Board Member | 75 | 11-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 9 M€ | +6.90% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.95 | +0.07% | 980,221 |
24-05-02 | 0.9493 | -0.96% | 940,873 |
24-05-01 | 0.9585 | +8.54% | 1,014,384 |
24-04-30 | 0.8831 | +2.09% | 539,086 |
24-04-29 | 0.865 | +10.04% | 1,143,869 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.74% | 63.51M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- BNGO Stock